Kiromic BioPharma's NSCLC T-cell Therapy Deltacel Continues to Provide Disease ...

Retrieved on: 2024-10-10 22:43:44

Tags for this article:

Orphan drugs

Biotechnology

Fluoroarenes

Kiromic BioPharma Inc.

Click the tags to see associated articles and topics

Kiromic BioPharma's NSCLC T-cell Therapy Deltacel Continues to Provide Disease .... View article details on hiswai:

Summary

Kiromic BioPharma's work on the investigational therapy Deltacel highlights advancements in biopharma, particularly related to biotechnology and orphan drugs, through innovative cancer treatments emerging from their clinical trials.

Article found on: www.cgtlive.com

View Original Article